DUBLIN--(http://www.researchandmarkets.com/research/wbqcg6/global_overactive) has announced the addition of the "Global Overactive Bladder Drug Pipeline Capsule - 2012 Update" report to their offering.)--Research and Markets (
“Global Overactive Bladder Drug Pipeline Capsule - 2012 Update”
Fore Pharma's latest report 'Global Overactive Bladder Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Overactive Bladder market. It covers active Overactive Bladder pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Overactive Bladder - Disease Overview
2. Overactive Bladder Pipeline Overview
3. Overactive Bladder Phase 3 Clinical Trial Pipeline Insights
4. Overactive Bladder Phase 2 Clinical Trial Pipeline Insights
5. Overactive Bladder Phase 1 Clinical Trial Pipeline Insights
6. Overactive Bladder Preclinical Research Pipeline Insights
7. Overactive Bladder Discovery Stage Pipeline Insights
8. Overactive Bladder Drug Development Activities - Geographic Landscape
8.1. Overactive Bladder R&D Activities in North America
8.2. Overactive Bladder R&D Activities in Europe
9. Overactive Bladder Pipeline - Licensing Activities
For more information visit http://www.researchandmarkets.com/research/wbqcg6/global_overactive